246 related articles for article (PubMed ID: 25442981)
21. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13.
Pimanda JE; Maekawa A; Wind T; Paxton J; Chesterman CN; Hogg PJ
Blood; 2004 Jan; 103(2):627-9. PubMed ID: 14512317
[TBL] [Abstract][Full Text] [Related]
22. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
23. ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.
Rurali E; Banterla F; Donadelli R; Bresin E; Galbusera M; Gastoldi S; Peyvandi F; Underwood M; Remuzzi G; Noris M
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2002-12. PubMed ID: 26342041
[TBL] [Abstract][Full Text] [Related]
24. Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patient.
Ferrari B; Cairo A; Pontiggia S; Mancini I; Masini L; Peyvandi F
J Clin Apher; 2015 Aug; 30(4):252-6. PubMed ID: 25367325
[TBL] [Abstract][Full Text] [Related]
25. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura.
Lotta LA; Garagiola I; Palla R; Cairo A; Peyvandi F
Hum Mutat; 2010 Jan; 31(1):11-9. PubMed ID: 19847791
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
[TBL] [Abstract][Full Text] [Related]
27. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.
Loirat C; Girma JP; Desconclois C; Coppo P; Veyradier A
Pediatr Nephrol; 2009 Jan; 24(1):19-29. PubMed ID: 18574602
[TBL] [Abstract][Full Text] [Related]
28. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
29. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
Shelat SG; Ai J; Zheng XL
Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
[TBL] [Abstract][Full Text] [Related]
30. Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.
Miodownik S; Pikovsky O; Erez O; Kezerle Y; Lavon O; Rabinovich A
Am J Obstet Gynecol; 2021 Aug; 225(2):177.e1-177.e15. PubMed ID: 33621545
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
Manea M; Kristoffersson A; Tsai HM; Zhou W; Winqvist I; Oldaeus G; Billström R; Björk P; Holmberg L; Karpman D
Eur J Pediatr; 2007 Mar; 166(3):249-57. PubMed ID: 17187257
[TBL] [Abstract][Full Text] [Related]
32. Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.
Rossio R; Ferrari B; Cairo A; Mancini I; Pisapia G; Palazzo G; Peyvandi F
Blood Transfus; 2013 Apr; 11(2):241-4. PubMed ID: 23058857
[TBL] [Abstract][Full Text] [Related]
33. Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.
Lotta LA; Wu HM; Mackie IJ; Noris M; Veyradier A; Scully MA; Remuzzi G; Coppo P; Liesner R; Donadelli R; Loirat C; Gibbs RA; Horne A; Yang S; Garagiola I; Musallam KM; Peyvandi F
Blood; 2012 Jul; 120(2):440-8. PubMed ID: 22529288
[TBL] [Abstract][Full Text] [Related]
34. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
George JN
Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency.
Assink K; Schiphorst R; Allford S; Karpman D; Etzioni A; Brichard B; van de Kar N; Monnens L; van den Heuvel L
Kidney Int; 2003 Jun; 63(6):1995-9. PubMed ID: 12753286
[TBL] [Abstract][Full Text] [Related]
36. [Identification of two novel mutations in ADAMTS13 gene in a patient with hereditary thrombotic thrombocytopenic purpura].
Liu F; Jin J; Dong NZ; Wang YG; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):521-4. PubMed ID: 16468327
[TBL] [Abstract][Full Text] [Related]
37. In vitro characterization of a novel Arg102 mutation in the ADAMTS13 metalloprotease domain.
De Waele L; Vermeersch L; Nguyen TT; Tersteeg C; De Meyer SF; Voet A; Pavenski K; Vanhoorelbeke K
J Thromb Haemost; 2023 Mar; 21(3):682-690. PubMed ID: 36696198
[TBL] [Abstract][Full Text] [Related]
38. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
39. The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura.
Lotta LA; Wu HM; Musallam KM; Peyvandi F
Blood Rev; 2013 Mar; 27(2):71-6. PubMed ID: 23415418
[TBL] [Abstract][Full Text] [Related]
40. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
Zhou W; Tsai HM
Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
